
jun pm et
summari one largest investor-own employe benefit organ
subsidiari major workplac provid employe benefit
price-to-earnings oper ep
structur strong cash flow divers wide rang
product howev competit intensifi
manag care market ci focu maintain
price disciplin weak economi contribut
declin enrol
aug ep estim base cfra oper earn
histor earn report compani report
stk
dividend paid sinc compani report
past perform indic futur perform
reli upon
forecast reliabl indic futur perform
past perform indic futur perform reli upon
analysi prepar equiti analyst
jun stock trade
march ci agre acquir
script esrx nation largest pharmaci
benefit manag pbm inclus
debt consist cash
ci share esrx share yet see
cross-sel estim
cost save synergi redund
administr cost provid
approv expect close
see sale exclus pend
esrx deal grow
membership growth premium increas
march ci member
year ago look membership
growth includ growth
medicar advantag ci abl sell
market sanction lift
juli ci lowest medic cost ratio
industri
commerci busi administr
servic aso arrang see ci
commerci medic cost ratio aid
signific aso busi see
govern cost ratio
see ep use tax
rate
hold recommend remain
cautiou ci pend esrx deal
view expens believ deal driven
primarili cost save initi
increas size leverag drug
manufactur combat high drug price
see limit synergist sale growth
opportun concern us
also believ contract
unitedhealthcar catamaran pbm
expir limit leverag
seek achiev despit comment
contractu flexibl separ
think ci add member
maintain lowest medic cost ratio
industri aso offer account
major plan see cost trend
next year ci current
limit particip exchang
plan seven state
risk recommend target price
includ intensifi competit
signific loss member
contractu loss higher-than-expect
target price base
peer ep estim due
concern expens acquisit
esrx
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
corpor overview one largest employe benefit organ provid health
care product servic well group life accid disabl insur
health offer group medic dental behavior health pharmaci servic product medic
product includ consum direct health plan cdhp hmo network point-of-servic po
plan prefer provid organ ppo tradit indemn coverag health care
product servic offer guarante cost retrospect experience-r
administr servic aso minimum premium fund arrang aso
employ plan sponsor self-fund claim assum risk claim cost incur
ci cdhp offer modular product portfolio provid choic benefit network variou
fund medic manag consumer health advocaci option employ consum
compani commerci oper segment includ commerci certain intern
health care busi serv employ employe group government
nongovernment organ union associ addit commerci health care
busi serv individu product offer public health insur
exchang segment compani offer insur self-insur custom medic
dental behavior health vision prescript drug benefit plan health advocaci program
product servic might integr part global health care benefit program
compani govern oper segment offer medicar advantag medicar part medicaid
compani offer medicar advantag plan state district columbia
health care benefit includ prescript drug manag care health plan
compani receiv revenu center medicar medicaid servic plan
custom base custom demograph data actual custom health risk factor compar
broader medicar popul compani might also earn addit revenu relat qualiti
perform measur known medicar star
compani medicar part prescript drug program provid variou plan option well servic
inform support medicar medicaid elig custom plan avail
state district columbia offer save medicar combin flexibl
provid improv benefit drug list tailor individu specif need
compani offer medicaid coverag low incom individu select market texa illinoi
medicaid custom benefit major coordin care aspect medicar advantag
disabl life provid employer-paid voluntari life accid disabl product held
group life insur polici oper select market outsid provid
individu group life accid health health care pension product
competit landscap accord insur inform institut health
insur compani unit state aet rank third enrol accord health care
industri inform provid atlant inform servic gener compet larg for-profit
manag care organ well local cross shield affili health plan local
own plan provider-sponsor plan think ci cost-reduct customer-servic
enhanc new product develop activ continu strengthen compani
financi trend revenu increas billion billion partli
aid afford care act healthcar marketplac exchang reflect three-year annual
compound annual growth rate compound-annual-growth-rate ep increas
reflect three-year compound-annual-growth-rate
chairman board
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
lt debt capit
analysi stock current worth base
figur base fiscal year-end price
cfra proprietari quantit model suggest
ci slightli under-valued
growth rate averag
neutral sinc june technic indic ci
neutral
lt debt capit
return equiti
net life insur
balanc sheet data million
equival
return revenu
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
fundament outlook manag health
care sub-industri next month
posit industri benefit
increas membership due afford
act includ medicaid expans
accord depart
million peopl obtain health insur
coverag primarili medicaid
expans public health exchang sinc
pass sinc octob
enrol medicaid expans
began enrol increas
million million howev note
mani larger health insur
significantli scale back complet
withdrawn particip healthcar
marketplac exchang due profit
challeng also individu mandat
requir peopl obtain health
insur repeal tax cut
job act effect see
demograph benefit peopl live
longer drive medicar advantag
fastest grow segment industri
peopl becom elig
sub-industri undergo signific
consolid includ transact
compani outsid health insur
industri transact
part predic form larger compani
establish leverag
pharmaceut market well healthcar
facil part sub-industri broader
share reduct csr program
help lower incom peopl sign
health insur marketplac
exchang pay out-of-pocket expens
includ co-pay deduct
believ elimin fund
result fewer peopl sign insur
health insur public
exchang million
shortli trump announc
republican senat lamar alexand
bipartisan deal continu csr payment
two year howev deal need
congression approv may
challeng hous republican
sizeabl major
help pay health care reform manag
fee total billion
period begin fee
tax includ compar effect
insur industri fee excis
fee start billion increas
everi year reach billion
fee increas premium
growth howev health insur
industri fee temporarili suspend
suspend well
meanwhil law place certain restrict
group start begin
commerci plan face floor
medic spend percentag
premium refer medic cost
ratio -- mcr medic loss ratio --
medicar advantag plan begin
 manag health index
rose vs rise
composit index year-to-d april
manag health index rose
vs declin
base index
five-year market price perform jun
note sector sub-industri inform base
past perform indic futur perform
reli upon
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
sale rose medic member increas
consolid medic care ratio improv ci
continu lose money exchang oper state
would surpris scale back particip due on-going
uncertainti particularli cost share reduct /jeffrey loo cfa
et cfra keep buy opinion share corpor ci
rais target in-lin peer
ep estim rais ep
ep vs ahead estim sale rose
broad-bas growth across segment cost associ exchang
member line expect ci undecid particip
level note ci limit particip exchang
offer plan state total membership rose million
expect remain level year-end /jeffrey loo cfa
corpor ci ci file lawsuit
termin merger deal spite appeal district
court rule block propos deal ci seek damag
addit break-up fee schedul receiv state ci
right termin deal extend deal agreement
end april remain commit close transact ci turn
state merger achiev regulatori approv
termin agreement best interest sharehold
corpor ci rais target
in-lin peer ep estim set ep estim
ep vs ahead estim premium
fee rose commerci govern medic care ratio
slightli lower expect ci see sale growth
ep membership growth expect court
decis deal soon anticip favor rule doj
block deal ci say capit deploy
analyst research note compani news
ci keep target below-p
ep estim remain cautiou pend
acquisit express script esrx ep vs
ahead view aid lower tax rate sale rose driven
increas medic membership member ci commerci
care ratio mcr govern mcr lower
expect aid resumpt health insur fee better cost
control spite signific flu season encourag
solid perform ci insur busi see limit synergist sale
growth esrx transact believ deal driven primarili
cost save goal greater leverag drug firm yet note
drug price pressur past year believ third
parti payer ci alreadi abl extract better price
et cfra keep hold opinion share script
hold co ci lift target
support esrx agreement today acquir health insur ci
enterpris valu billion esrx sharehold receiv
cash ci share current per esrx share
think deal make strateg sens help exrx better compet
vertically-integr competitor secur esrx relationship
last remain independ larg health plan provid ahead contract
expir end expect deal close end /joseph
et cfra lower view share corpor hold
buy ci ci agre buy express script
includ debt consist cash ci share
esrx share view deal driven cost save goal
greater leverag drug firm lower price rather growth
opportun ci small in-hous pbm note long-term
contract unitedhealthcar catamaran believ
limit leverag despit ci statement contractu
flexibl lower target below-p
ep estim /jeffrey loo cfa
rais target line peer
ep estim aid lower tax set
ep vs estim
sale rose increas premium fee ci end
member think ci could add member driven growth
commerci busi increas medicar advantag member
ci abl sell segment sanction lift
anticip take time build momentum marketplac
rais target slightli peer
forward ep estim ep vs
view rais ep estim
sale rose medic membership rose
member driven commerci busi partial off-set
govern busi commerci medic care ratio improv vs
last quarter see growth medicar advantag market ci abl
sell segment sanction lift juli /jeffrey loo cfa
rais target in-lin peer
forward ep estim ep vs
ahead estim rais ep estim
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim ci earn
usd quarter fiscal year ci
announc earn per share usd repres
total revenu estim fiscal year
analyst estim ci earn per share grow
usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut standard
 poor malaysia sdn bhd cfra malaysia certain research distribut
cfra uk limit cfra uk cfra uk cfra malaysia wholly-own
subsidiari cfra us
abbrevi use equiti research report
ebit earn interest tax
redistribut reproduct prohibit without prior written permiss copyright cfra
